Global Therapeutic Peptide APIs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Therapeutic peptide APIs (Active Pharmaceutical Ingredients) are specific peptides developed for use in pharmaceutical drugs to treat various diseases and medical conditions. Peptides are short chains of amino acids linked by peptide bonds, and they can mimic or influence biological processes, making them suitable for therapeutic purposes.
The global Therapeutic Peptide APIs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Therapeutic Peptide APIs Industry Forecast” looks at past sales and reviews total world Therapeutic Peptide APIs sales in 2023, providing a comprehensive analysis by region and market sector of projected Therapeutic Peptide APIs sales for 2024 through 2030. With Therapeutic Peptide APIs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Peptide APIs industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Peptide APIs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Peptide APIs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Peptide APIs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Peptide APIs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Peptide APIs.
United States market for Therapeutic Peptide APIs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Therapeutic Peptide APIs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Therapeutic Peptide APIs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Therapeutic Peptide APIs players cover Bachem, GenScript, AmbioPharm, Limitless Biotech, CPC Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Peptide APIs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Therapeutic Peptide APIs market?
What factors are driving Therapeutic Peptide APIs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Peptide APIs market opportunities vary by end market size?
How does Therapeutic Peptide APIs break out by Type, by Application?
Therapeutic peptide APIs (Active Pharmaceutical Ingredients) are specific peptides developed for use in pharmaceutical drugs to treat various diseases and medical conditions. Peptides are short chains of amino acids linked by peptide bonds, and they can mimic or influence biological processes, making them suitable for therapeutic purposes.
The global Therapeutic Peptide APIs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Therapeutic Peptide APIs Industry Forecast” looks at past sales and reviews total world Therapeutic Peptide APIs sales in 2023, providing a comprehensive analysis by region and market sector of projected Therapeutic Peptide APIs sales for 2024 through 2030. With Therapeutic Peptide APIs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Peptide APIs industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Peptide APIs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Peptide APIs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Peptide APIs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Peptide APIs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Peptide APIs.
United States market for Therapeutic Peptide APIs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Therapeutic Peptide APIs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Therapeutic Peptide APIs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Therapeutic Peptide APIs players cover Bachem, GenScript, AmbioPharm, Limitless Biotech, CPC Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Peptide APIs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Bioactive Peptides
- Synthetic Peptides
- Pharmaceuticals
- Scientific Research
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bachem
- GenScript
- AmbioPharm
- Limitless Biotech
- CPC Scientific
- PolyPeptide
- CordenPharma
- Lonza
- Aspen API
- Syngene
- USV Peptides
- Bio Basic
- JPT Peptide Technologies
- ScinoPharm
- Piramal Pharma
- Jiangsu Sinopep-Allsino Biopharmaceutical
- Cheng Du Sheng Nuo Biotec
- Hybio Pharmaceutical
- Hainan Shuangcheng Pharmaceuticals
- Guangdong Jianyuan Pharmaceutical
- Zhejiang Peptites Biotech
What is the 10-year outlook for the global Therapeutic Peptide APIs market?
What factors are driving Therapeutic Peptide APIs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Peptide APIs market opportunities vary by end market size?
How does Therapeutic Peptide APIs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Peptide APIs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Therapeutic Peptide APIs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Therapeutic Peptide APIs by Country/Region, 2019, 2023 & 2030
2.2 Therapeutic Peptide APIs Segment by Type
2.2.1 Bioactive Peptides
2.2.2 Synthetic Peptides
2.3 Therapeutic Peptide APIs Sales by Type
2.3.1 Global Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
2.3.2 Global Therapeutic Peptide APIs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Therapeutic Peptide APIs Sale Price by Type (2019-2024)
2.4 Therapeutic Peptide APIs Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Scientific Research
2.4.3 Other
2.5 Therapeutic Peptide APIs Sales by Application
2.5.1 Global Therapeutic Peptide APIs Sale Market Share by Application (2019-2024)
2.5.2 Global Therapeutic Peptide APIs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Therapeutic Peptide APIs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Therapeutic Peptide APIs Breakdown Data by Company
3.1.1 Global Therapeutic Peptide APIs Annual Sales by Company (2019-2024)
3.1.2 Global Therapeutic Peptide APIs Sales Market Share by Company (2019-2024)
3.2 Global Therapeutic Peptide APIs Annual Revenue by Company (2019-2024)
3.2.1 Global Therapeutic Peptide APIs Revenue by Company (2019-2024)
3.2.2 Global Therapeutic Peptide APIs Revenue Market Share by Company (2019-2024)
3.3 Global Therapeutic Peptide APIs Sale Price by Company
3.4 Key Manufacturers Therapeutic Peptide APIs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Peptide APIs Product Location Distribution
3.4.2 Players Therapeutic Peptide APIs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC PEPTIDE APIS BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Peptide APIs Market Size by Geographic Region (2019-2024)
4.1.1 Global Therapeutic Peptide APIs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Therapeutic Peptide APIs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Therapeutic Peptide APIs Market Size by Country/Region (2019-2024)
4.2.1 Global Therapeutic Peptide APIs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Therapeutic Peptide APIs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Therapeutic Peptide APIs Sales Growth
4.4 APAC Therapeutic Peptide APIs Sales Growth
4.5 Europe Therapeutic Peptide APIs Sales Growth
4.6 Middle East & Africa Therapeutic Peptide APIs Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Peptide APIs Sales by Country
5.1.1 Americas Therapeutic Peptide APIs Sales by Country (2019-2024)
5.1.2 Americas Therapeutic Peptide APIs Revenue by Country (2019-2024)
5.2 Americas Therapeutic Peptide APIs Sales by Type (2019-2024)
5.3 Americas Therapeutic Peptide APIs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Peptide APIs Sales by Region
6.1.1 APAC Therapeutic Peptide APIs Sales by Region (2019-2024)
6.1.2 APAC Therapeutic Peptide APIs Revenue by Region (2019-2024)
6.2 APAC Therapeutic Peptide APIs Sales by Type (2019-2024)
6.3 APAC Therapeutic Peptide APIs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Peptide APIs by Country
7.1.1 Europe Therapeutic Peptide APIs Sales by Country (2019-2024)
7.1.2 Europe Therapeutic Peptide APIs Revenue by Country (2019-2024)
7.2 Europe Therapeutic Peptide APIs Sales by Type (2019-2024)
7.3 Europe Therapeutic Peptide APIs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Peptide APIs by Country
8.1.1 Middle East & Africa Therapeutic Peptide APIs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Therapeutic Peptide APIs Revenue by Country (2019-2024)
8.2 Middle East & Africa Therapeutic Peptide APIs Sales by Type (2019-2024)
8.3 Middle East & Africa Therapeutic Peptide APIs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Peptide APIs
10.3 Manufacturing Process Analysis of Therapeutic Peptide APIs
10.4 Industry Chain Structure of Therapeutic Peptide APIs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Peptide APIs Distributors
11.3 Therapeutic Peptide APIs Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC PEPTIDE APIS BY GEOGRAPHIC REGION
12.1 Global Therapeutic Peptide APIs Market Size Forecast by Region
12.1.1 Global Therapeutic Peptide APIs Forecast by Region (2025-2030)
12.1.2 Global Therapeutic Peptide APIs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Therapeutic Peptide APIs Forecast by Type (2025-2030)
12.7 Global Therapeutic Peptide APIs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Bachem
13.1.1 Bachem Company Information
13.1.2 Bachem Therapeutic Peptide APIs Product Portfolios and Specifications
13.1.3 Bachem Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bachem Main Business Overview
13.1.5 Bachem Latest Developments
13.2 GenScript
13.2.1 GenScript Company Information
13.2.2 GenScript Therapeutic Peptide APIs Product Portfolios and Specifications
13.2.3 GenScript Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GenScript Main Business Overview
13.2.5 GenScript Latest Developments
13.3 AmbioPharm
13.3.1 AmbioPharm Company Information
13.3.2 AmbioPharm Therapeutic Peptide APIs Product Portfolios and Specifications
13.3.3 AmbioPharm Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 AmbioPharm Main Business Overview
13.3.5 AmbioPharm Latest Developments
13.4 Limitless Biotech
13.4.1 Limitless Biotech Company Information
13.4.2 Limitless Biotech Therapeutic Peptide APIs Product Portfolios and Specifications
13.4.3 Limitless Biotech Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Limitless Biotech Main Business Overview
13.4.5 Limitless Biotech Latest Developments
13.5 CPC Scientific
13.5.1 CPC Scientific Company Information
13.5.2 CPC Scientific Therapeutic Peptide APIs Product Portfolios and Specifications
13.5.3 CPC Scientific Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CPC Scientific Main Business Overview
13.5.5 CPC Scientific Latest Developments
13.6 PolyPeptide
13.6.1 PolyPeptide Company Information
13.6.2 PolyPeptide Therapeutic Peptide APIs Product Portfolios and Specifications
13.6.3 PolyPeptide Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 PolyPeptide Main Business Overview
13.6.5 PolyPeptide Latest Developments
13.7 CordenPharma
13.7.1 CordenPharma Company Information
13.7.2 CordenPharma Therapeutic Peptide APIs Product Portfolios and Specifications
13.7.3 CordenPharma Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 CordenPharma Main Business Overview
13.7.5 CordenPharma Latest Developments
13.8 Lonza
13.8.1 Lonza Company Information
13.8.2 Lonza Therapeutic Peptide APIs Product Portfolios and Specifications
13.8.3 Lonza Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Lonza Main Business Overview
13.8.5 Lonza Latest Developments
13.9 Aspen API
13.9.1 Aspen API Company Information
13.9.2 Aspen API Therapeutic Peptide APIs Product Portfolios and Specifications
13.9.3 Aspen API Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Aspen API Main Business Overview
13.9.5 Aspen API Latest Developments
13.10 Syngene
13.10.1 Syngene Company Information
13.10.2 Syngene Therapeutic Peptide APIs Product Portfolios and Specifications
13.10.3 Syngene Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Syngene Main Business Overview
13.10.5 Syngene Latest Developments
13.11 USV Peptides
13.11.1 USV Peptides Company Information
13.11.2 USV Peptides Therapeutic Peptide APIs Product Portfolios and Specifications
13.11.3 USV Peptides Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 USV Peptides Main Business Overview
13.11.5 USV Peptides Latest Developments
13.12 Bio Basic
13.12.1 Bio Basic Company Information
13.12.2 Bio Basic Therapeutic Peptide APIs Product Portfolios and Specifications
13.12.3 Bio Basic Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Bio Basic Main Business Overview
13.12.5 Bio Basic Latest Developments
13.13 JPT Peptide Technologies
13.13.1 JPT Peptide Technologies Company Information
13.13.2 JPT Peptide Technologies Therapeutic Peptide APIs Product Portfolios and Specifications
13.13.3 JPT Peptide Technologies Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 JPT Peptide Technologies Main Business Overview
13.13.5 JPT Peptide Technologies Latest Developments
13.14 ScinoPharm
13.14.1 ScinoPharm Company Information
13.14.2 ScinoPharm Therapeutic Peptide APIs Product Portfolios and Specifications
13.14.3 ScinoPharm Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 ScinoPharm Main Business Overview
13.14.5 ScinoPharm Latest Developments
13.15 Piramal Pharma
13.15.1 Piramal Pharma Company Information
13.15.2 Piramal Pharma Therapeutic Peptide APIs Product Portfolios and Specifications
13.15.3 Piramal Pharma Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Piramal Pharma Main Business Overview
13.15.5 Piramal Pharma Latest Developments
13.16 Jiangsu Sinopep-Allsino Biopharmaceutical
13.16.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
13.16.2 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
13.16.3 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Jiangsu Sinopep-Allsino Biopharmaceutical Main Business Overview
13.16.5 Jiangsu Sinopep-Allsino Biopharmaceutical Latest Developments
13.17 Cheng Du Sheng Nuo Biotec
13.17.1 Cheng Du Sheng Nuo Biotec Company Information
13.17.2 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product Portfolios and Specifications
13.17.3 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Cheng Du Sheng Nuo Biotec Main Business Overview
13.17.5 Cheng Du Sheng Nuo Biotec Latest Developments
13.18 Hybio Pharmaceutical
13.18.1 Hybio Pharmaceutical Company Information
13.18.2 Hybio Pharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
13.18.3 Hybio Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Hybio Pharmaceutical Main Business Overview
13.18.5 Hybio Pharmaceutical Latest Developments
13.19 Hainan Shuangcheng Pharmaceuticals
13.19.1 Hainan Shuangcheng Pharmaceuticals Company Information
13.19.2 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product Portfolios and Specifications
13.19.3 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Hainan Shuangcheng Pharmaceuticals Main Business Overview
13.19.5 Hainan Shuangcheng Pharmaceuticals Latest Developments
13.20 Guangdong Jianyuan Pharmaceutical
13.20.1 Guangdong Jianyuan Pharmaceutical Company Information
13.20.2 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
13.20.3 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Guangdong Jianyuan Pharmaceutical Main Business Overview
13.20.5 Guangdong Jianyuan Pharmaceutical Latest Developments
13.21 Zhejiang Peptites Biotech
13.21.1 Zhejiang Peptites Biotech Company Information
13.21.2 Zhejiang Peptites Biotech Therapeutic Peptide APIs Product Portfolios and Specifications
13.21.3 Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Zhejiang Peptites Biotech Main Business Overview
13.21.5 Zhejiang Peptites Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Peptide APIs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Therapeutic Peptide APIs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Therapeutic Peptide APIs by Country/Region, 2019, 2023 & 2030
2.2 Therapeutic Peptide APIs Segment by Type
2.2.1 Bioactive Peptides
2.2.2 Synthetic Peptides
2.3 Therapeutic Peptide APIs Sales by Type
2.3.1 Global Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
2.3.2 Global Therapeutic Peptide APIs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Therapeutic Peptide APIs Sale Price by Type (2019-2024)
2.4 Therapeutic Peptide APIs Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Scientific Research
2.4.3 Other
2.5 Therapeutic Peptide APIs Sales by Application
2.5.1 Global Therapeutic Peptide APIs Sale Market Share by Application (2019-2024)
2.5.2 Global Therapeutic Peptide APIs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Therapeutic Peptide APIs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Therapeutic Peptide APIs Breakdown Data by Company
3.1.1 Global Therapeutic Peptide APIs Annual Sales by Company (2019-2024)
3.1.2 Global Therapeutic Peptide APIs Sales Market Share by Company (2019-2024)
3.2 Global Therapeutic Peptide APIs Annual Revenue by Company (2019-2024)
3.2.1 Global Therapeutic Peptide APIs Revenue by Company (2019-2024)
3.2.2 Global Therapeutic Peptide APIs Revenue Market Share by Company (2019-2024)
3.3 Global Therapeutic Peptide APIs Sale Price by Company
3.4 Key Manufacturers Therapeutic Peptide APIs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Peptide APIs Product Location Distribution
3.4.2 Players Therapeutic Peptide APIs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC PEPTIDE APIS BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Peptide APIs Market Size by Geographic Region (2019-2024)
4.1.1 Global Therapeutic Peptide APIs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Therapeutic Peptide APIs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Therapeutic Peptide APIs Market Size by Country/Region (2019-2024)
4.2.1 Global Therapeutic Peptide APIs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Therapeutic Peptide APIs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Therapeutic Peptide APIs Sales Growth
4.4 APAC Therapeutic Peptide APIs Sales Growth
4.5 Europe Therapeutic Peptide APIs Sales Growth
4.6 Middle East & Africa Therapeutic Peptide APIs Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Peptide APIs Sales by Country
5.1.1 Americas Therapeutic Peptide APIs Sales by Country (2019-2024)
5.1.2 Americas Therapeutic Peptide APIs Revenue by Country (2019-2024)
5.2 Americas Therapeutic Peptide APIs Sales by Type (2019-2024)
5.3 Americas Therapeutic Peptide APIs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Peptide APIs Sales by Region
6.1.1 APAC Therapeutic Peptide APIs Sales by Region (2019-2024)
6.1.2 APAC Therapeutic Peptide APIs Revenue by Region (2019-2024)
6.2 APAC Therapeutic Peptide APIs Sales by Type (2019-2024)
6.3 APAC Therapeutic Peptide APIs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Peptide APIs by Country
7.1.1 Europe Therapeutic Peptide APIs Sales by Country (2019-2024)
7.1.2 Europe Therapeutic Peptide APIs Revenue by Country (2019-2024)
7.2 Europe Therapeutic Peptide APIs Sales by Type (2019-2024)
7.3 Europe Therapeutic Peptide APIs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Peptide APIs by Country
8.1.1 Middle East & Africa Therapeutic Peptide APIs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Therapeutic Peptide APIs Revenue by Country (2019-2024)
8.2 Middle East & Africa Therapeutic Peptide APIs Sales by Type (2019-2024)
8.3 Middle East & Africa Therapeutic Peptide APIs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Peptide APIs
10.3 Manufacturing Process Analysis of Therapeutic Peptide APIs
10.4 Industry Chain Structure of Therapeutic Peptide APIs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Peptide APIs Distributors
11.3 Therapeutic Peptide APIs Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC PEPTIDE APIS BY GEOGRAPHIC REGION
12.1 Global Therapeutic Peptide APIs Market Size Forecast by Region
12.1.1 Global Therapeutic Peptide APIs Forecast by Region (2025-2030)
12.1.2 Global Therapeutic Peptide APIs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Therapeutic Peptide APIs Forecast by Type (2025-2030)
12.7 Global Therapeutic Peptide APIs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Bachem
13.1.1 Bachem Company Information
13.1.2 Bachem Therapeutic Peptide APIs Product Portfolios and Specifications
13.1.3 Bachem Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bachem Main Business Overview
13.1.5 Bachem Latest Developments
13.2 GenScript
13.2.1 GenScript Company Information
13.2.2 GenScript Therapeutic Peptide APIs Product Portfolios and Specifications
13.2.3 GenScript Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GenScript Main Business Overview
13.2.5 GenScript Latest Developments
13.3 AmbioPharm
13.3.1 AmbioPharm Company Information
13.3.2 AmbioPharm Therapeutic Peptide APIs Product Portfolios and Specifications
13.3.3 AmbioPharm Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 AmbioPharm Main Business Overview
13.3.5 AmbioPharm Latest Developments
13.4 Limitless Biotech
13.4.1 Limitless Biotech Company Information
13.4.2 Limitless Biotech Therapeutic Peptide APIs Product Portfolios and Specifications
13.4.3 Limitless Biotech Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Limitless Biotech Main Business Overview
13.4.5 Limitless Biotech Latest Developments
13.5 CPC Scientific
13.5.1 CPC Scientific Company Information
13.5.2 CPC Scientific Therapeutic Peptide APIs Product Portfolios and Specifications
13.5.3 CPC Scientific Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 CPC Scientific Main Business Overview
13.5.5 CPC Scientific Latest Developments
13.6 PolyPeptide
13.6.1 PolyPeptide Company Information
13.6.2 PolyPeptide Therapeutic Peptide APIs Product Portfolios and Specifications
13.6.3 PolyPeptide Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 PolyPeptide Main Business Overview
13.6.5 PolyPeptide Latest Developments
13.7 CordenPharma
13.7.1 CordenPharma Company Information
13.7.2 CordenPharma Therapeutic Peptide APIs Product Portfolios and Specifications
13.7.3 CordenPharma Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 CordenPharma Main Business Overview
13.7.5 CordenPharma Latest Developments
13.8 Lonza
13.8.1 Lonza Company Information
13.8.2 Lonza Therapeutic Peptide APIs Product Portfolios and Specifications
13.8.3 Lonza Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Lonza Main Business Overview
13.8.5 Lonza Latest Developments
13.9 Aspen API
13.9.1 Aspen API Company Information
13.9.2 Aspen API Therapeutic Peptide APIs Product Portfolios and Specifications
13.9.3 Aspen API Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Aspen API Main Business Overview
13.9.5 Aspen API Latest Developments
13.10 Syngene
13.10.1 Syngene Company Information
13.10.2 Syngene Therapeutic Peptide APIs Product Portfolios and Specifications
13.10.3 Syngene Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Syngene Main Business Overview
13.10.5 Syngene Latest Developments
13.11 USV Peptides
13.11.1 USV Peptides Company Information
13.11.2 USV Peptides Therapeutic Peptide APIs Product Portfolios and Specifications
13.11.3 USV Peptides Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 USV Peptides Main Business Overview
13.11.5 USV Peptides Latest Developments
13.12 Bio Basic
13.12.1 Bio Basic Company Information
13.12.2 Bio Basic Therapeutic Peptide APIs Product Portfolios and Specifications
13.12.3 Bio Basic Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Bio Basic Main Business Overview
13.12.5 Bio Basic Latest Developments
13.13 JPT Peptide Technologies
13.13.1 JPT Peptide Technologies Company Information
13.13.2 JPT Peptide Technologies Therapeutic Peptide APIs Product Portfolios and Specifications
13.13.3 JPT Peptide Technologies Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 JPT Peptide Technologies Main Business Overview
13.13.5 JPT Peptide Technologies Latest Developments
13.14 ScinoPharm
13.14.1 ScinoPharm Company Information
13.14.2 ScinoPharm Therapeutic Peptide APIs Product Portfolios and Specifications
13.14.3 ScinoPharm Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 ScinoPharm Main Business Overview
13.14.5 ScinoPharm Latest Developments
13.15 Piramal Pharma
13.15.1 Piramal Pharma Company Information
13.15.2 Piramal Pharma Therapeutic Peptide APIs Product Portfolios and Specifications
13.15.3 Piramal Pharma Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Piramal Pharma Main Business Overview
13.15.5 Piramal Pharma Latest Developments
13.16 Jiangsu Sinopep-Allsino Biopharmaceutical
13.16.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
13.16.2 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
13.16.3 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Jiangsu Sinopep-Allsino Biopharmaceutical Main Business Overview
13.16.5 Jiangsu Sinopep-Allsino Biopharmaceutical Latest Developments
13.17 Cheng Du Sheng Nuo Biotec
13.17.1 Cheng Du Sheng Nuo Biotec Company Information
13.17.2 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product Portfolios and Specifications
13.17.3 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Cheng Du Sheng Nuo Biotec Main Business Overview
13.17.5 Cheng Du Sheng Nuo Biotec Latest Developments
13.18 Hybio Pharmaceutical
13.18.1 Hybio Pharmaceutical Company Information
13.18.2 Hybio Pharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
13.18.3 Hybio Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Hybio Pharmaceutical Main Business Overview
13.18.5 Hybio Pharmaceutical Latest Developments
13.19 Hainan Shuangcheng Pharmaceuticals
13.19.1 Hainan Shuangcheng Pharmaceuticals Company Information
13.19.2 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product Portfolios and Specifications
13.19.3 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Hainan Shuangcheng Pharmaceuticals Main Business Overview
13.19.5 Hainan Shuangcheng Pharmaceuticals Latest Developments
13.20 Guangdong Jianyuan Pharmaceutical
13.20.1 Guangdong Jianyuan Pharmaceutical Company Information
13.20.2 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
13.20.3 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Guangdong Jianyuan Pharmaceutical Main Business Overview
13.20.5 Guangdong Jianyuan Pharmaceutical Latest Developments
13.21 Zhejiang Peptites Biotech
13.21.1 Zhejiang Peptites Biotech Company Information
13.21.2 Zhejiang Peptites Biotech Therapeutic Peptide APIs Product Portfolios and Specifications
13.21.3 Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Zhejiang Peptites Biotech Main Business Overview
13.21.5 Zhejiang Peptites Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Therapeutic Peptide APIs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Therapeutic Peptide APIs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Bioactive Peptides
Table 4. Major Players of Synthetic Peptides
Table 5. Global Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 6. Global Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Table 7. Global Therapeutic Peptide APIs Revenue by Type (2019-2024) & ($ million)
Table 8. Global Therapeutic Peptide APIs Revenue Market Share by Type (2019-2024)
Table 9. Global Therapeutic Peptide APIs Sale Price by Type (2019-2024) & (US$/kg)
Table 10. Global Therapeutic Peptide APIs Sale by Application (2019-2024) & (Tons)
Table 11. Global Therapeutic Peptide APIs Sale Market Share by Application (2019-2024)
Table 12. Global Therapeutic Peptide APIs Revenue by Application (2019-2024) & ($ million)
Table 13. Global Therapeutic Peptide APIs Revenue Market Share by Application (2019-2024)
Table 14. Global Therapeutic Peptide APIs Sale Price by Application (2019-2024) & (US$/kg)
Table 15. Global Therapeutic Peptide APIs Sales by Company (2019-2024) & (Tons)
Table 16. Global Therapeutic Peptide APIs Sales Market Share by Company (2019-2024)
Table 17. Global Therapeutic Peptide APIs Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Therapeutic Peptide APIs Revenue Market Share by Company (2019-2024)
Table 19. Global Therapeutic Peptide APIs Sale Price by Company (2019-2024) & (US$/kg)
Table 20. Key Manufacturers Therapeutic Peptide APIs Producing Area Distribution and Sales Area
Table 21. Players Therapeutic Peptide APIs Products Offered
Table 22. Therapeutic Peptide APIs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Therapeutic Peptide APIs Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Therapeutic Peptide APIs Sales Market Share Geographic Region (2019-2024)
Table 27. Global Therapeutic Peptide APIs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Therapeutic Peptide APIs Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Therapeutic Peptide APIs Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Therapeutic Peptide APIs Sales Market Share by Country/Region (2019-2024)
Table 31. Global Therapeutic Peptide APIs Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Therapeutic Peptide APIs Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
Table 34. Americas Therapeutic Peptide APIs Sales Market Share by Country (2019-2024)
Table 35. Americas Therapeutic Peptide APIs Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 37. Americas Therapeutic Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 38. APAC Therapeutic Peptide APIs Sales by Region (2019-2024) & (Tons)
Table 39. APAC Therapeutic Peptide APIs Sales Market Share by Region (2019-2024)
Table 40. APAC Therapeutic Peptide APIs Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 42. APAC Therapeutic Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 43. Europe Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
Table 44. Europe Therapeutic Peptide APIs Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 46. Europe Therapeutic Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Therapeutic Peptide APIs Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 50. Middle East & Africa Therapeutic Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Therapeutic Peptide APIs
Table 52. Key Market Challenges & Risks of Therapeutic Peptide APIs
Table 53. Key Industry Trends of Therapeutic Peptide APIs
Table 54. Therapeutic Peptide APIs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Therapeutic Peptide APIs Distributors List
Table 57. Therapeutic Peptide APIs Customer List
Table 58. Global Therapeutic Peptide APIs Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global Therapeutic Peptide APIs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Therapeutic Peptide APIs Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas Therapeutic Peptide APIs Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Therapeutic Peptide APIs Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC Therapeutic Peptide APIs Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Therapeutic Peptide APIs Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe Therapeutic Peptide APIs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Therapeutic Peptide APIs Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Therapeutic Peptide APIs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Therapeutic Peptide APIs Sales Forecast by Type (2025-2030) & (Tons)
Table 69. Global Therapeutic Peptide APIs Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Therapeutic Peptide APIs Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global Therapeutic Peptide APIs Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Bachem Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 73. Bachem Therapeutic Peptide APIs Product Portfolios and Specifications
Table 74. Bachem Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 75. Bachem Main Business
Table 76. Bachem Latest Developments
Table 77. GenScript Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 78. GenScript Therapeutic Peptide APIs Product Portfolios and Specifications
Table 79. GenScript Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 80. GenScript Main Business
Table 81. GenScript Latest Developments
Table 82. AmbioPharm Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 83. AmbioPharm Therapeutic Peptide APIs Product Portfolios and Specifications
Table 84. AmbioPharm Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 85. AmbioPharm Main Business
Table 86. AmbioPharm Latest Developments
Table 87. Limitless Biotech Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 88. Limitless Biotech Therapeutic Peptide APIs Product Portfolios and Specifications
Table 89. Limitless Biotech Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 90. Limitless Biotech Main Business
Table 91. Limitless Biotech Latest Developments
Table 92. CPC Scientific Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 93. CPC Scientific Therapeutic Peptide APIs Product Portfolios and Specifications
Table 94. CPC Scientific Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 95. CPC Scientific Main Business
Table 96. CPC Scientific Latest Developments
Table 97. PolyPeptide Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 98. PolyPeptide Therapeutic Peptide APIs Product Portfolios and Specifications
Table 99. PolyPeptide Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 100. PolyPeptide Main Business
Table 101. PolyPeptide Latest Developments
Table 102. CordenPharma Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 103. CordenPharma Therapeutic Peptide APIs Product Portfolios and Specifications
Table 104. CordenPharma Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 105. CordenPharma Main Business
Table 106. CordenPharma Latest Developments
Table 107. Lonza Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 108. Lonza Therapeutic Peptide APIs Product Portfolios and Specifications
Table 109. Lonza Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 110. Lonza Main Business
Table 111. Lonza Latest Developments
Table 112. Aspen API Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 113. Aspen API Therapeutic Peptide APIs Product Portfolios and Specifications
Table 114. Aspen API Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 115. Aspen API Main Business
Table 116. Aspen API Latest Developments
Table 117. Syngene Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 118. Syngene Therapeutic Peptide APIs Product Portfolios and Specifications
Table 119. Syngene Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 120. Syngene Main Business
Table 121. Syngene Latest Developments
Table 122. USV Peptides Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 123. USV Peptides Therapeutic Peptide APIs Product Portfolios and Specifications
Table 124. USV Peptides Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 125. USV Peptides Main Business
Table 126. USV Peptides Latest Developments
Table 127. Bio Basic Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 128. Bio Basic Therapeutic Peptide APIs Product Portfolios and Specifications
Table 129. Bio Basic Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 130. Bio Basic Main Business
Table 131. Bio Basic Latest Developments
Table 132. JPT Peptide Technologies Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 133. JPT Peptide Technologies Therapeutic Peptide APIs Product Portfolios and Specifications
Table 134. JPT Peptide Technologies Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 135. JPT Peptide Technologies Main Business
Table 136. JPT Peptide Technologies Latest Developments
Table 137. ScinoPharm Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 138. ScinoPharm Therapeutic Peptide APIs Product Portfolios and Specifications
Table 139. ScinoPharm Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 140. ScinoPharm Main Business
Table 141. ScinoPharm Latest Developments
Table 142. Piramal Pharma Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 143. Piramal Pharma Therapeutic Peptide APIs Product Portfolios and Specifications
Table 144. Piramal Pharma Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 145. Piramal Pharma Main Business
Table 146. Piramal Pharma Latest Developments
Table 147. Jiangsu Sinopep-Allsino Biopharmaceutical Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
Table 149. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 150. Jiangsu Sinopep-Allsino Biopharmaceutical Main Business
Table 151. Jiangsu Sinopep-Allsino Biopharmaceutical Latest Developments
Table 152. Cheng Du Sheng Nuo Biotec Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 153. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product Portfolios and Specifications
Table 154. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 155. Cheng Du Sheng Nuo Biotec Main Business
Table 156. Cheng Du Sheng Nuo Biotec Latest Developments
Table 157. Hybio Pharmaceutical Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 158. Hybio Pharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
Table 159. Hybio Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 160. Hybio Pharmaceutical Main Business
Table 161. Hybio Pharmaceutical Latest Developments
Table 162. Hainan Shuangcheng Pharmaceuticals Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 163. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product Portfolios and Specifications
Table 164. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 165. Hainan Shuangcheng Pharmaceuticals Main Business
Table 166. Hainan Shuangcheng Pharmaceuticals Latest Developments
Table 167. Guangdong Jianyuan Pharmaceutical Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 168. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
Table 169. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 170. Guangdong Jianyuan Pharmaceutical Main Business
Table 171. Guangdong Jianyuan Pharmaceutical Latest Developments
Table 172. Zhejiang Peptites Biotech Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 173. Zhejiang Peptites Biotech Therapeutic Peptide APIs Product Portfolios and Specifications
Table 174. Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 175. Zhejiang Peptites Biotech Main Business
Table 176. Zhejiang Peptites Biotech Latest Developments
Table 1. Therapeutic Peptide APIs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Therapeutic Peptide APIs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Bioactive Peptides
Table 4. Major Players of Synthetic Peptides
Table 5. Global Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 6. Global Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Table 7. Global Therapeutic Peptide APIs Revenue by Type (2019-2024) & ($ million)
Table 8. Global Therapeutic Peptide APIs Revenue Market Share by Type (2019-2024)
Table 9. Global Therapeutic Peptide APIs Sale Price by Type (2019-2024) & (US$/kg)
Table 10. Global Therapeutic Peptide APIs Sale by Application (2019-2024) & (Tons)
Table 11. Global Therapeutic Peptide APIs Sale Market Share by Application (2019-2024)
Table 12. Global Therapeutic Peptide APIs Revenue by Application (2019-2024) & ($ million)
Table 13. Global Therapeutic Peptide APIs Revenue Market Share by Application (2019-2024)
Table 14. Global Therapeutic Peptide APIs Sale Price by Application (2019-2024) & (US$/kg)
Table 15. Global Therapeutic Peptide APIs Sales by Company (2019-2024) & (Tons)
Table 16. Global Therapeutic Peptide APIs Sales Market Share by Company (2019-2024)
Table 17. Global Therapeutic Peptide APIs Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Therapeutic Peptide APIs Revenue Market Share by Company (2019-2024)
Table 19. Global Therapeutic Peptide APIs Sale Price by Company (2019-2024) & (US$/kg)
Table 20. Key Manufacturers Therapeutic Peptide APIs Producing Area Distribution and Sales Area
Table 21. Players Therapeutic Peptide APIs Products Offered
Table 22. Therapeutic Peptide APIs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Therapeutic Peptide APIs Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Therapeutic Peptide APIs Sales Market Share Geographic Region (2019-2024)
Table 27. Global Therapeutic Peptide APIs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Therapeutic Peptide APIs Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Therapeutic Peptide APIs Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Therapeutic Peptide APIs Sales Market Share by Country/Region (2019-2024)
Table 31. Global Therapeutic Peptide APIs Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Therapeutic Peptide APIs Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
Table 34. Americas Therapeutic Peptide APIs Sales Market Share by Country (2019-2024)
Table 35. Americas Therapeutic Peptide APIs Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 37. Americas Therapeutic Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 38. APAC Therapeutic Peptide APIs Sales by Region (2019-2024) & (Tons)
Table 39. APAC Therapeutic Peptide APIs Sales Market Share by Region (2019-2024)
Table 40. APAC Therapeutic Peptide APIs Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 42. APAC Therapeutic Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 43. Europe Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
Table 44. Europe Therapeutic Peptide APIs Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 46. Europe Therapeutic Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Therapeutic Peptide APIs Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Therapeutic Peptide APIs Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Therapeutic Peptide APIs Sales by Type (2019-2024) & (Tons)
Table 50. Middle East & Africa Therapeutic Peptide APIs Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Therapeutic Peptide APIs
Table 52. Key Market Challenges & Risks of Therapeutic Peptide APIs
Table 53. Key Industry Trends of Therapeutic Peptide APIs
Table 54. Therapeutic Peptide APIs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Therapeutic Peptide APIs Distributors List
Table 57. Therapeutic Peptide APIs Customer List
Table 58. Global Therapeutic Peptide APIs Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global Therapeutic Peptide APIs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Therapeutic Peptide APIs Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas Therapeutic Peptide APIs Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Therapeutic Peptide APIs Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC Therapeutic Peptide APIs Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Therapeutic Peptide APIs Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe Therapeutic Peptide APIs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Therapeutic Peptide APIs Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Therapeutic Peptide APIs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Therapeutic Peptide APIs Sales Forecast by Type (2025-2030) & (Tons)
Table 69. Global Therapeutic Peptide APIs Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Therapeutic Peptide APIs Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global Therapeutic Peptide APIs Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Bachem Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 73. Bachem Therapeutic Peptide APIs Product Portfolios and Specifications
Table 74. Bachem Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 75. Bachem Main Business
Table 76. Bachem Latest Developments
Table 77. GenScript Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 78. GenScript Therapeutic Peptide APIs Product Portfolios and Specifications
Table 79. GenScript Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 80. GenScript Main Business
Table 81. GenScript Latest Developments
Table 82. AmbioPharm Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 83. AmbioPharm Therapeutic Peptide APIs Product Portfolios and Specifications
Table 84. AmbioPharm Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 85. AmbioPharm Main Business
Table 86. AmbioPharm Latest Developments
Table 87. Limitless Biotech Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 88. Limitless Biotech Therapeutic Peptide APIs Product Portfolios and Specifications
Table 89. Limitless Biotech Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 90. Limitless Biotech Main Business
Table 91. Limitless Biotech Latest Developments
Table 92. CPC Scientific Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 93. CPC Scientific Therapeutic Peptide APIs Product Portfolios and Specifications
Table 94. CPC Scientific Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 95. CPC Scientific Main Business
Table 96. CPC Scientific Latest Developments
Table 97. PolyPeptide Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 98. PolyPeptide Therapeutic Peptide APIs Product Portfolios and Specifications
Table 99. PolyPeptide Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 100. PolyPeptide Main Business
Table 101. PolyPeptide Latest Developments
Table 102. CordenPharma Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 103. CordenPharma Therapeutic Peptide APIs Product Portfolios and Specifications
Table 104. CordenPharma Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 105. CordenPharma Main Business
Table 106. CordenPharma Latest Developments
Table 107. Lonza Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 108. Lonza Therapeutic Peptide APIs Product Portfolios and Specifications
Table 109. Lonza Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 110. Lonza Main Business
Table 111. Lonza Latest Developments
Table 112. Aspen API Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 113. Aspen API Therapeutic Peptide APIs Product Portfolios and Specifications
Table 114. Aspen API Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 115. Aspen API Main Business
Table 116. Aspen API Latest Developments
Table 117. Syngene Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 118. Syngene Therapeutic Peptide APIs Product Portfolios and Specifications
Table 119. Syngene Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 120. Syngene Main Business
Table 121. Syngene Latest Developments
Table 122. USV Peptides Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 123. USV Peptides Therapeutic Peptide APIs Product Portfolios and Specifications
Table 124. USV Peptides Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 125. USV Peptides Main Business
Table 126. USV Peptides Latest Developments
Table 127. Bio Basic Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 128. Bio Basic Therapeutic Peptide APIs Product Portfolios and Specifications
Table 129. Bio Basic Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 130. Bio Basic Main Business
Table 131. Bio Basic Latest Developments
Table 132. JPT Peptide Technologies Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 133. JPT Peptide Technologies Therapeutic Peptide APIs Product Portfolios and Specifications
Table 134. JPT Peptide Technologies Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 135. JPT Peptide Technologies Main Business
Table 136. JPT Peptide Technologies Latest Developments
Table 137. ScinoPharm Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 138. ScinoPharm Therapeutic Peptide APIs Product Portfolios and Specifications
Table 139. ScinoPharm Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 140. ScinoPharm Main Business
Table 141. ScinoPharm Latest Developments
Table 142. Piramal Pharma Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 143. Piramal Pharma Therapeutic Peptide APIs Product Portfolios and Specifications
Table 144. Piramal Pharma Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 145. Piramal Pharma Main Business
Table 146. Piramal Pharma Latest Developments
Table 147. Jiangsu Sinopep-Allsino Biopharmaceutical Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
Table 149. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 150. Jiangsu Sinopep-Allsino Biopharmaceutical Main Business
Table 151. Jiangsu Sinopep-Allsino Biopharmaceutical Latest Developments
Table 152. Cheng Du Sheng Nuo Biotec Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 153. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product Portfolios and Specifications
Table 154. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 155. Cheng Du Sheng Nuo Biotec Main Business
Table 156. Cheng Du Sheng Nuo Biotec Latest Developments
Table 157. Hybio Pharmaceutical Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 158. Hybio Pharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
Table 159. Hybio Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 160. Hybio Pharmaceutical Main Business
Table 161. Hybio Pharmaceutical Latest Developments
Table 162. Hainan Shuangcheng Pharmaceuticals Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 163. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product Portfolios and Specifications
Table 164. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 165. Hainan Shuangcheng Pharmaceuticals Main Business
Table 166. Hainan Shuangcheng Pharmaceuticals Latest Developments
Table 167. Guangdong Jianyuan Pharmaceutical Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 168. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product Portfolios and Specifications
Table 169. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 170. Guangdong Jianyuan Pharmaceutical Main Business
Table 171. Guangdong Jianyuan Pharmaceutical Latest Developments
Table 172. Zhejiang Peptites Biotech Basic Information, Therapeutic Peptide APIs Manufacturing Base, Sales Area and Its Competitors
Table 173. Zhejiang Peptites Biotech Therapeutic Peptide APIs Product Portfolios and Specifications
Table 174. Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 175. Zhejiang Peptites Biotech Main Business
Table 176. Zhejiang Peptites Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Therapeutic Peptide APIs
Figure 2. Therapeutic Peptide APIs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Peptide APIs Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Therapeutic Peptide APIs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Therapeutic Peptide APIs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Therapeutic Peptide APIs Sales Market Share by Country/Region (2023)
Figure 10. Therapeutic Peptide APIs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Bioactive Peptides
Figure 12. Product Picture of Synthetic Peptides
Figure 13. Global Therapeutic Peptide APIs Sales Market Share by Type in 2023
Figure 14. Global Therapeutic Peptide APIs Revenue Market Share by Type (2019-2024)
Figure 15. Therapeutic Peptide APIs Consumed in Pharmaceuticals
Figure 16. Global Therapeutic Peptide APIs Market: Pharmaceuticals (2019-2024) & (Tons)
Figure 17. Therapeutic Peptide APIs Consumed in Scientific Research
Figure 18. Global Therapeutic Peptide APIs Market: Scientific Research (2019-2024) & (Tons)
Figure 19. Therapeutic Peptide APIs Consumed in Other
Figure 20. Global Therapeutic Peptide APIs Market: Other (2019-2024) & (Tons)
Figure 21. Global Therapeutic Peptide APIs Sale Market Share by Application (2023)
Figure 22. Global Therapeutic Peptide APIs Revenue Market Share by Application in 2023
Figure 23. Therapeutic Peptide APIs Sales by Company in 2023 (Tons)
Figure 24. Global Therapeutic Peptide APIs Sales Market Share by Company in 2023
Figure 25. Therapeutic Peptide APIs Revenue by Company in 2023 ($ millions)
Figure 26. Global Therapeutic Peptide APIs Revenue Market Share by Company in 2023
Figure 27. Global Therapeutic Peptide APIs Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Therapeutic Peptide APIs Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Therapeutic Peptide APIs Sales 2019-2024 (Tons)
Figure 30. Americas Therapeutic Peptide APIs Revenue 2019-2024 ($ millions)
Figure 31. APAC Therapeutic Peptide APIs Sales 2019-2024 (Tons)
Figure 32. APAC Therapeutic Peptide APIs Revenue 2019-2024 ($ millions)
Figure 33. Europe Therapeutic Peptide APIs Sales 2019-2024 (Tons)
Figure 34. Europe Therapeutic Peptide APIs Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Therapeutic Peptide APIs Sales 2019-2024 (Tons)
Figure 36. Middle East & Africa Therapeutic Peptide APIs Revenue 2019-2024 ($ millions)
Figure 37. Americas Therapeutic Peptide APIs Sales Market Share by Country in 2023
Figure 38. Americas Therapeutic Peptide APIs Revenue Market Share by Country (2019-2024)
Figure 39. Americas Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Figure 40. Americas Therapeutic Peptide APIs Sales Market Share by Application (2019-2024)
Figure 41. United States Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Therapeutic Peptide APIs Sales Market Share by Region in 2023
Figure 46. APAC Therapeutic Peptide APIs Revenue Market Share by Region (2019-2024)
Figure 47. APAC Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Figure 48. APAC Therapeutic Peptide APIs Sales Market Share by Application (2019-2024)
Figure 49. China Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 53. India Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Therapeutic Peptide APIs Sales Market Share by Country in 2023
Figure 57. Europe Therapeutic Peptide APIs Revenue Market Share by Country (2019-2024)
Figure 58. Europe Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Figure 59. Europe Therapeutic Peptide APIs Sales Market Share by Application (2019-2024)
Figure 60. Germany Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 61. France Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Therapeutic Peptide APIs Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Therapeutic Peptide APIs Sales Market Share by Application (2019-2024)
Figure 68. Egypt Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Therapeutic Peptide APIs in 2023
Figure 74. Manufacturing Process Analysis of Therapeutic Peptide APIs
Figure 75. Industry Chain Structure of Therapeutic Peptide APIs
Figure 76. Channels of Distribution
Figure 77. Global Therapeutic Peptide APIs Sales Market Forecast by Region (2025-2030)
Figure 78. Global Therapeutic Peptide APIs Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Therapeutic Peptide APIs Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Therapeutic Peptide APIs Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Therapeutic Peptide APIs Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Therapeutic Peptide APIs Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Therapeutic Peptide APIs
Figure 2. Therapeutic Peptide APIs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Peptide APIs Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Therapeutic Peptide APIs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Therapeutic Peptide APIs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Therapeutic Peptide APIs Sales Market Share by Country/Region (2023)
Figure 10. Therapeutic Peptide APIs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Bioactive Peptides
Figure 12. Product Picture of Synthetic Peptides
Figure 13. Global Therapeutic Peptide APIs Sales Market Share by Type in 2023
Figure 14. Global Therapeutic Peptide APIs Revenue Market Share by Type (2019-2024)
Figure 15. Therapeutic Peptide APIs Consumed in Pharmaceuticals
Figure 16. Global Therapeutic Peptide APIs Market: Pharmaceuticals (2019-2024) & (Tons)
Figure 17. Therapeutic Peptide APIs Consumed in Scientific Research
Figure 18. Global Therapeutic Peptide APIs Market: Scientific Research (2019-2024) & (Tons)
Figure 19. Therapeutic Peptide APIs Consumed in Other
Figure 20. Global Therapeutic Peptide APIs Market: Other (2019-2024) & (Tons)
Figure 21. Global Therapeutic Peptide APIs Sale Market Share by Application (2023)
Figure 22. Global Therapeutic Peptide APIs Revenue Market Share by Application in 2023
Figure 23. Therapeutic Peptide APIs Sales by Company in 2023 (Tons)
Figure 24. Global Therapeutic Peptide APIs Sales Market Share by Company in 2023
Figure 25. Therapeutic Peptide APIs Revenue by Company in 2023 ($ millions)
Figure 26. Global Therapeutic Peptide APIs Revenue Market Share by Company in 2023
Figure 27. Global Therapeutic Peptide APIs Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Therapeutic Peptide APIs Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Therapeutic Peptide APIs Sales 2019-2024 (Tons)
Figure 30. Americas Therapeutic Peptide APIs Revenue 2019-2024 ($ millions)
Figure 31. APAC Therapeutic Peptide APIs Sales 2019-2024 (Tons)
Figure 32. APAC Therapeutic Peptide APIs Revenue 2019-2024 ($ millions)
Figure 33. Europe Therapeutic Peptide APIs Sales 2019-2024 (Tons)
Figure 34. Europe Therapeutic Peptide APIs Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Therapeutic Peptide APIs Sales 2019-2024 (Tons)
Figure 36. Middle East & Africa Therapeutic Peptide APIs Revenue 2019-2024 ($ millions)
Figure 37. Americas Therapeutic Peptide APIs Sales Market Share by Country in 2023
Figure 38. Americas Therapeutic Peptide APIs Revenue Market Share by Country (2019-2024)
Figure 39. Americas Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Figure 40. Americas Therapeutic Peptide APIs Sales Market Share by Application (2019-2024)
Figure 41. United States Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Therapeutic Peptide APIs Sales Market Share by Region in 2023
Figure 46. APAC Therapeutic Peptide APIs Revenue Market Share by Region (2019-2024)
Figure 47. APAC Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Figure 48. APAC Therapeutic Peptide APIs Sales Market Share by Application (2019-2024)
Figure 49. China Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 53. India Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Therapeutic Peptide APIs Sales Market Share by Country in 2023
Figure 57. Europe Therapeutic Peptide APIs Revenue Market Share by Country (2019-2024)
Figure 58. Europe Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Figure 59. Europe Therapeutic Peptide APIs Sales Market Share by Application (2019-2024)
Figure 60. Germany Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 61. France Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Therapeutic Peptide APIs Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Therapeutic Peptide APIs Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Therapeutic Peptide APIs Sales Market Share by Application (2019-2024)
Figure 68. Egypt Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Therapeutic Peptide APIs Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Therapeutic Peptide APIs in 2023
Figure 74. Manufacturing Process Analysis of Therapeutic Peptide APIs
Figure 75. Industry Chain Structure of Therapeutic Peptide APIs
Figure 76. Channels of Distribution
Figure 77. Global Therapeutic Peptide APIs Sales Market Forecast by Region (2025-2030)
Figure 78. Global Therapeutic Peptide APIs Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Therapeutic Peptide APIs Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Therapeutic Peptide APIs Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Therapeutic Peptide APIs Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Therapeutic Peptide APIs Revenue Market Share Forecast by Application (2025-2030)
